filmov
tv
Define challenges of tissue-based biomarker development for Immuno-Oncology Therapy
Показать описание
Presented By: Houssein Sater, MD
Speaker Biography: Dr. Sater is a translational physician scientist (hematologist/oncologist) with special interest in immune therapy of cancer. He leads the Genitourinary Malignancies Branch efforts at understanding the role of cancer immunotherapy on the tumor (immune and non-immune) micro-environment.
Webinar: Define challenges of tissue-based biomarker development for Immuno-Oncology Therapy
Webinar Abstract: Cancer immunotherapy had revolutionized the field of oncology, providing noveltherapeutic options for cancer patients with dramatically improved outcomes. However, the development of the new field of immuno-oncology requires a deep understanding of the inflammatory tumor microenvironment with the goal to identify predictive biomarkers for immunotherapy.
Earn PACE Credits:
LabRoots on Social:
SnapChat: labroots_inc
Speaker Biography: Dr. Sater is a translational physician scientist (hematologist/oncologist) with special interest in immune therapy of cancer. He leads the Genitourinary Malignancies Branch efforts at understanding the role of cancer immunotherapy on the tumor (immune and non-immune) micro-environment.
Webinar: Define challenges of tissue-based biomarker development for Immuno-Oncology Therapy
Webinar Abstract: Cancer immunotherapy had revolutionized the field of oncology, providing noveltherapeutic options for cancer patients with dramatically improved outcomes. However, the development of the new field of immuno-oncology requires a deep understanding of the inflammatory tumor microenvironment with the goal to identify predictive biomarkers for immunotherapy.
Earn PACE Credits:
LabRoots on Social:
SnapChat: labroots_inc
0:56:51
0:44:23
0:07:12
0:46:59
0:01:29
0:45:55
0:55:15
0:27:49
0:49:57
1:12:38
0:03:05
0:06:08
1:02:07
0:32:22
0:49:54
0:57:40
0:29:55
0:59:32
0:05:33
1:21:52
2:29:28
0:47:51
1:06:29
0:37:31